Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience

Autor: Oriol Rodríguez-Leor, Belén Cid-Álvarez, Armando Pérez de Prado, Xavier Rossello, Soledad Ojeda, Ana Serrador, Ramón López-Palop, Javier Martín-Moreiras, José Ramón Rumoroso, Ángel Cequier, Borja Ibáñez, Ignacio Cruz-González, Rafael Romaguera, Raúl Moreno, Manuel Villa, Rafael Ruíz-Salmerón, Francisco Molano, Carlos Sánchez, Erika Muñoz-García, Luís Íñigo, Juan Herrador, Antonio Gómez-Menchero, Juan Caballero, Mérida Cárdenas, Livia Gheorghe, Jesús Oneto, Francisco Morales, Félix Valencia, José Ramón Ruíz, José Antonio Diarte, Pablo Avanzas, Juan Rondán, Vicente Peral, Lucía Vera Pernasetti, Julio Hernández, Francisco Bosa, Pedro Luís Martín Lorenzo, Francisco Jiménez, José M de la Torre Hernández, Jesús Jiménez-Mazuecos, Fernando Lozano, José Moreu, Enrique Novo, Javier Robles, Javier Martín Moreiras, Felipe Fernández-Vázquez, Ignacio J. Amat-Santos, Joan Antoni Gómez-Hospital, Joan García-Picart, Bruno García del Blanco, Ander Regueiro, Xavier Carrillo-Suárez, Helena Tizón, Mohsen Mohandes, Juan Casanova, Víctor Agudelo-Montañez, Juan Francisco Muñoz, Juan Franco, Roberto del Castillo, Pablo Salinas, Jaime Elizaga, Fernando Sarnago, Santiago Jiménez-Valero, Fernando Rivero, Juan Francisco Oteo, Eduardo Alegría-Barrero, Ángel Sánchez-Recalde, Valeriano Ruíz, Eduardo Pinar, Ana Planas, Bernabé López Ledesma, Alberto Berenguer, Agustín Fernández-Cisnal, Pablo Aguar, Francisco Pomar, Miguel Jerez, Francisco Torres, Ricardo García, Araceli Frutos, Juan Miguel Ruíz Nodar, Koldobika García, Roberto Sáez, Alfonso Torres, Miren Tellería, Mario Sadaba, José Ramón López Mínguez, Juan Carlos Rama Merchán, Javier Portales, Ramiro Trillo, Guillermo Aldama, Saleta Fernández, Melisa Santás, María Pilar Portero Pérez
Rok vydání: 2020
Předmět:
Male
medicine.medical_treatment
Artículo Original
Myocardial Infarction
Comorbidity
030204 cardiovascular system & hematology
STEMI network
IAMCEST
0302 clinical medicine
PCR
polymerase chain reaction
ST segment
ICPp
intervención coronaria percutánea primaria
Myocardial infarction
Hospital Mortality
Registries
COVID-19
coronavirus disease 2019
PCR
reacción en cadena de la polimerasa
Disease Management
General Medicine
Middle Aged
Editorial
COVID-19
enfermedad por coronavirus de 2019
Original Article
Female
STEMI
ST-segment elevation acute myocardial infarction
medicine.medical_specialty
Angioplastia primaria
ICP
intervención coronaria percutánea
IAMCEST
infarto agudo de miocardio con elevación del segmento ST
STEMI
03 medical and health sciences
Percutaneous Coronary Intervention
Internal medicine
medicine
Humans
cardiovascular diseases
pPCI
primary percutaneous coronary intervention
Pandemics
Primary angioplasty
Retrospective Studies
PCI
percutaneous coronary intervention
business.industry
SARS-CoV-2
Outbreak
Percutaneous coronary intervention
COVID-19
Retrospective cohort study
medicine.disease
Spain
Conventional PCI
Red de atención al infarto
ST Elevation Myocardial Infarction
Observational study
business
Follow-Up Studies
Zdroj: Revista Espanola De Cardiologia (English Ed.)
Revista Espanola De Cardiologia
Revista Española de Cardiología (English Edition)
ISSN: 1885-5857
Popis: Introduction and objectives The COVID-19 outbreak has had an unclear impact on the treatment and outcomes of patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study was to assess changes in STEMI management during the COVID-19 outbreak. Methods Using a multicenter, nationwide, retrospective, observational registry of consecutive patients who were managed in 75 specific STEMI care centers in Spain, we compared patient and procedural characteristics and in-hospital outcomes in 2 different cohorts with 30-day follow-up according to whether the patients had been treated before or after COVID-19. Results Suspected STEMI patients treated in STEMI networks decreased by 27.6% and patients with confirmed STEMI fell from 1305 to 1009 (22.7%). There were no differences in reperfusion strategy (> 94% treated with primary percutaneous coronary intervention in both cohorts). Patients treated with primary percutaneous coronary intervention during the COVID-19 outbreak had a longer ischemic time (233 [150-375] vs 200 [140-332] minutes, P
Databáze: OpenAIRE
Externí odkaz: